---
title: 'CLinical EValuation of WEB 17 device in intracranial aneuRysms (CLEVER): procedural,
  30-day and 1-year safety results for ruptured and unruptured aneurysms'
date: '2023-11-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37914392/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231102180753&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Endovascular treatment of ruptured and unruptured wide-neck
  bifurcation aneurysms using WEB 17 is safe, with a low complication rate and no
  device-related mortality. In particular, none of the ruptured aneurysms bled again
  up to 1 year of ...'
disable_comments: true
---
CONCLUSION: Endovascular treatment of ruptured and unruptured wide-neck bifurcation aneurysms using WEB 17 is safe, with a low complication rate and no device-related mortality. In particular, none of the ruptured aneurysms bled again up to 1 year of ...